Table 3. Symptom response to capecitabine/MMC.
| Symptom | Proportion of patients with baseline symptoms resolving on therapy | % |
|---|---|---|
| Pain | 14/18 | 77.8 |
| Lethargy | 9/22 | 40.9 |
| Altered bowel habit | 7/10 | 70 |
| Dyspnoea | 5/6 | 83.3 |
| Anorexia | 3/6 | 50 |
| Weight loss | 2/4 | 50 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.